Limited Time Offer$99 GLP-1 Injections: While Supplies Last
2026 Pricing Audit & Clinical Analysis

Telehealth FX vs Henry Meds: Compounded GLP-1 Cost Comparison

Julian Mercer, M.S.
Julian Mercer, M.S. · Clinical Healthcare Economics
Independent Price Benchmark · Updated September 2026 · 11 min read
Amber pharmaceutical apothecary dropper vials on sculptured stone pedestal in bright minimalist clinical setting
Editorial Still Life · Archival Photographic Standard
Direct Comparative Resolution

Henry Meds charges $297 monthly for compounded semaglutide and $449 monthly for compounded tirzepatide. In comparison, Telehealth FX provides identical 503A clinical quality for a flat $146 monthly for semaglutide and $258 monthly for tirzepatide across all doses, saving patients $1,812 to $2,292 annually without long-term commitments.

Side-by-Side Monthly Outlay: Telehealth FX vs Henry Meds

Both platforms partner with state-licensed 503A compounding pharmacies, but their pricing models create substantial cost disparities:

Treatment ProgramTelehealth FXHenry MedsAnnual Savings with Telehealth FX
Compounded Semaglutide (Injectable)Flat $146/mo ($99 Mo 1)$297 / monthSave $1,812 / year
Compounded Tirzepatide (Injectable)Flat $258/mo ($99 Mo 1)$449 / monthSave $2,292 / year
Oral Sublingual TabletsAvailable from $146/mo$249 / monthSave $1,236 / year
Doctor Check-ins & Consults$0 (Free & Unlimited)Included in priceEqual clinical access
Prescription Transfer Guarantee

Paying $449/Month with Henry Meds? Switch to Flat $258

Switch your compounded Tirzepatide or Semaglutide prescription to Telehealth FX in minutes. Maintain your existing dose without starting over, and save up to $191 every single month.

Transfer from Henry Meds ($99 Month 1)

The Clinical Parity: Why Pay a 74% Mark-Up?

Patients often assume higher prices correlate with superior medication quality. In federal pharmaceutical compounding under 21 U.S.C. § 353a, this assumption is false.

Both Telehealth FX and Henry Meds utilize FDA-registered 503A state compounding pharmacies that acquire pure active pharmaceutical ingredient (API) powder tested to United States Pharmacopeia (USP) standards. The $191 monthly difference on Tirzepatide represents pure markup and marketing expense.

Switch to Telehealth FX Today

Same active incretin molecules, same 503A sterile standards, but at honest flat-rate pricing. Get started online in under 5 minutes.

Check Your Eligibility Now